There has been a big selloff in Sequenom’s shares  (SQNM) end of April. This has been caused by mishandling of test results by Sequenom’s employees, it is not clear whether deliberate however, investigations are pending. Sequenom worked on a blood test against down syndrom for pregnant women, which is much faster and less invasive than current methods. [...]

Read the rest of this entry »